The neurocutaneous syndrome is a group of neurologic disorders of brain, spine, and the peripheral nervous system. These diseases are lifelong conditions that may induce a tumor growth inside the skin, organs, skeletal bones, brain, and spinal cord. These disorders are usually genetic and arise due to abnormal cell development at the embryo stage. The result is characterized by the development of tumors in various parts of the body. Even though some can be diagnosed at birth, most of them do not display symptoms until late.
This report aims to provide a comprehensive presentation of the global market for Neurocutaneous Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurocutaneous Disorder. This report contains market size and forecasts of Neurocutaneous Disorder in global, including the following market information:
Global Neurocutaneous Disorder Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Neurocutaneous Disorder market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas region accounted for the largest market share of the global neurocutaneous disorder market owing to the increasing awareness about genetic disorders along with the growing number of drug and medical service providers.
We surveyed the Neurocutaneous Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurocutaneous Disorder Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Neurocutaneous Disorder Market Segment Percentages, by Type, 2022 (%)
Tuberous Sclerosis (TS)
Neurofibromatosis (NF)
Sturge-Weber Syndrome
Von Hippel-Lindau (VHL)
Ataxia-Telangiectasia (A-T)
Others
Global Neurocutaneous Disorder Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Neurocutaneous Disorder Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Diagnostic Centers
Others
Global Neurocutaneous Disorder Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Neurocutaneous Disorder Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurocutaneous Disorder revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neurocutaneous Disorder revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Medtronic
Abbott
Novartis
Roche
Sanofi
Takeda
Allergan
Syneron Medical
Aleva NeurOthersapeutics
Abbott Laboratories
Bausch Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurocutaneous Disorder, market overview.
Chapter 2: Global Neurocutaneous Disorder market size in revenue.
Chapter 3: Detailed analysis of Neurocutaneous Disorder company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurocutaneous Disorder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neurocutaneous Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurocutaneous Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurocutaneous Disorder Overall Market Size
2.1 Global Neurocutaneous Disorder Market Size: 2022 VS 2030
2.2 Global Neurocutaneous Disorder Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurocutaneous Disorder Players in Global Market
3.2 Top Global Neurocutaneous Disorder Companies Ranked by Revenue
3.3 Global Neurocutaneous Disorder Revenue by Companies
3.4 Top 3 and Top 5 Neurocutaneous Disorder Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neurocutaneous Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurocutaneous Disorder Players in Global Market
3.6.1 List of Global Tier 1 Neurocutaneous Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurocutaneous Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurocutaneous Disorder Market Size Markets, 2022 & 2030
4.1.2 Tuberous Sclerosis (TS)
4.1.3 Neurofibromatosis (NF)
4.1.4 Sturge-Weber Syndrome
4.1.5 Von Hippel-Lindau (VHL)
4.1.6 Ataxia-Telangiectasia (A-T)
4.1.7 Others
4.2 By Type - Global Neurocutaneous Disorder Revenue & Forecasts
4.2.1 By Type - Global Neurocutaneous Disorder Revenue, 2018-2023
4.2.2 By Type - Global Neurocutaneous Disorder Revenue, 2024-2030
4.2.3 By Type - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurocutaneous Disorder Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Neurocutaneous Disorder Revenue & Forecasts
5.2.1 By Application - Global Neurocutaneous Disorder Revenue, 2018-2023
5.2.2 By Application - Global Neurocutaneous Disorder Revenue, 2024-2030
5.2.3 By Application - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Neurocutaneous Disorder Market Size, 2022 & 2030
6.2 By Region - Global Neurocutaneous Disorder Revenue & Forecasts
6.2.1 By Region - Global Neurocutaneous Disorder Revenue, 2018-2023
6.2.2 By Region - Global Neurocutaneous Disorder Revenue, 2024-2030
6.2.3 By Region - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Neurocutaneous Disorder Revenue, 2018-2030
6.3.2 US Neurocutaneous Disorder Market Size, 2018-2030
6.3.3 Canada Neurocutaneous Disorder Market Size, 2018-2030
6.3.4 Mexico Neurocutaneous Disorder Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Neurocutaneous Disorder Revenue, 2018-2030
6.4.2 Germany Neurocutaneous Disorder Market Size, 2018-2030
6.4.3 France Neurocutaneous Disorder Market Size, 2018-2030
6.4.4 U.K. Neurocutaneous Disorder Market Size, 2018-2030
6.4.5 Italy Neurocutaneous Disorder Market Size, 2018-2030
6.4.6 Russia Neurocutaneous Disorder Market Size, 2018-2030
6.4.7 Nordic Countries Neurocutaneous Disorder Market Size, 2018-2030
6.4.8 Benelux Neurocutaneous Disorder Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Neurocutaneous Disorder Revenue, 2018-2030
6.5.2 China Neurocutaneous Disorder Market Size, 2018-2030
6.5.3 Japan Neurocutaneous Disorder Market Size, 2018-2030
6.5.4 South Korea Neurocutaneous Disorder Market Size, 2018-2030
6.5.5 Southeast Asia Neurocutaneous Disorder Market Size, 2018-2030
6.5.6 India Neurocutaneous Disorder Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Neurocutaneous Disorder Revenue, 2018-2030
6.6.2 Brazil Neurocutaneous Disorder Market Size, 2018-2030
6.6.3 Argentina Neurocutaneous Disorder Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurocutaneous Disorder Revenue, 2018-2030
6.7.2 Turkey Neurocutaneous Disorder Market Size, 2018-2030
6.7.3 Israel Neurocutaneous Disorder Market Size, 2018-2030
6.7.4 Saudi Arabia Neurocutaneous Disorder Market Size, 2018-2030
6.7.5 UAE Neurocutaneous Disorder Market Size, 2018-2030
7 Neurocutaneous Disorder Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neurocutaneous Disorder Major Product Offerings
7.1.4 Pfizer Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Neurocutaneous Disorder Major Product Offerings
7.2.4 Johnson & Johnson Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Medtronic
7.3.1 Medtronic Company Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Neurocutaneous Disorder Major Product Offerings
7.3.4 Medtronic Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.3.5 Medtronic Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Neurocutaneous Disorder Major Product Offerings
7.4.4 Abbott Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Neurocutaneous Disorder Major Product Offerings
7.5.4 Novartis Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Neurocutaneous Disorder Major Product Offerings
7.6.4 Roche Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Neurocutaneous Disorder Major Product Offerings
7.7.4 Sanofi Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Neurocutaneous Disorder Major Product Offerings
7.8.4 Takeda Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 Allergan
7.9.1 Allergan Company Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Neurocutaneous Disorder Major Product Offerings
7.9.4 Allergan Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.9.5 Allergan Key News & Latest Developments
7.10 Syneron Medical
7.10.1 Syneron Medical Company Summary
7.10.2 Syneron Medical Business Overview
7.10.3 Syneron Medical Neurocutaneous Disorder Major Product Offerings
7.10.4 Syneron Medical Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.10.5 Syneron Medical Key News & Latest Developments
7.11 Aleva NeurOthersapeutics
7.11.1 Aleva NeurOthersapeutics Company Summary
7.11.2 Aleva NeurOthersapeutics Business Overview
7.11.3 Aleva NeurOthersapeutics Neurocutaneous Disorder Major Product Offerings
7.11.4 Aleva NeurOthersapeutics Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.11.5 Aleva NeurOthersapeutics Key News & Latest Developments
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Company Summary
7.12.2 Abbott Laboratories Business Overview
7.12.3 Abbott Laboratories Neurocutaneous Disorder Major Product Offerings
7.12.4 Abbott Laboratories Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.12.5 Abbott Laboratories Key News & Latest Developments
7.13 Bausch Health
7.13.1 Bausch Health Company Summary
7.13.2 Bausch Health Business Overview
7.13.3 Bausch Health Neurocutaneous Disorder Major Product Offerings
7.13.4 Bausch Health Neurocutaneous Disorder Revenue in Global Market (2018-2023)
7.13.5 Bausch Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Neurocutaneous Disorder Market Opportunities & Trends in Global Market
Table 2. Neurocutaneous Disorder Market Drivers in Global Market
Table 3. Neurocutaneous Disorder Market Restraints in Global Market
Table 4. Key Players of Neurocutaneous Disorder in Global Market
Table 5. Top Neurocutaneous Disorder Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Neurocutaneous Disorder Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Neurocutaneous Disorder Revenue Share by Companies, 2018-2023
Table 8. Global Companies Neurocutaneous Disorder Product Type
Table 9. List of Global Tier 1 Neurocutaneous Disorder Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurocutaneous Disorder Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neurocutaneous Disorder Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Neurocutaneous Disorder Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Neurocutaneous Disorder Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Neurocutaneous Disorder Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Neurocutaneous Disorder Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Neurocutaneous Disorder Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Neurocutaneous Disorder Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Neurocutaneous Disorder Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Neurocutaneous Disorder Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Neurocutaneous Disorder Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Neurocutaneous Disorder Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Neurocutaneous Disorder Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Neurocutaneous Disorder Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Neurocutaneous Disorder Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Neurocutaneous Disorder Product Offerings
Table 32. Pfizer Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Neurocutaneous Disorder Product Offerings
Table 36. Johnson & Johnson Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Medtronic Company Summary
Table 39. Medtronic Neurocutaneous Disorder Product Offerings
Table 40. Medtronic Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 41. Medtronic Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Neurocutaneous Disorder Product Offerings
Table 44. Abbott Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Neurocutaneous Disorder Product Offerings
Table 48. Novartis Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Neurocutaneous Disorder Product Offerings
Table 52. Roche Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Neurocutaneous Disorder Product Offerings
Table 56. Sanofi Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Takeda Company Summary
Table 59. Takeda Neurocutaneous Disorder Product Offerings
Table 60. Takeda Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Key News & Latest Developments
Table 62. Allergan Company Summary
Table 63. Allergan Neurocutaneous Disorder Product Offerings
Table 64. Allergan Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 65. Allergan Key News & Latest Developments
Table 66. Syneron Medical Company Summary
Table 67. Syneron Medical Neurocutaneous Disorder Product Offerings
Table 68. Syneron Medical Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 69. Syneron Medical Key News & Latest Developments
Table 70. Aleva NeurOthersapeutics Company Summary
Table 71. Aleva NeurOthersapeutics Neurocutaneous Disorder Product Offerings
Table 72. Aleva NeurOthersapeutics Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 73. Aleva NeurOthersapeutics Key News & Latest Developments
Table 74. Abbott Laboratories Company Summary
Table 75. Abbott Laboratories Neurocutaneous Disorder Product Offerings
Table 76. Abbott Laboratories Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 77. Abbott Laboratories Key News & Latest Developments
Table 78. Bausch Health Company Summary
Table 79. Bausch Health Neurocutaneous Disorder Product Offerings
Table 80. Bausch Health Neurocutaneous Disorder Revenue (US$, Mn) & (2018-2023)
Table 81. Bausch Health Key News & Latest Developments
List of Figures
Figure 1. Neurocutaneous Disorder Segment by Type in 2022
Figure 2. Neurocutaneous Disorder Segment by Application in 2022
Figure 3. Global Neurocutaneous Disorder Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neurocutaneous Disorder Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Neurocutaneous Disorder Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurocutaneous Disorder Revenue in 2022
Figure 8. By Type - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 9. By Application - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 10. By Type - Global Neurocutaneous Disorder Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 12. By Application - Global Neurocutaneous Disorder Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 14. By Region - Global Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 15. By Country - North America Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 16. US Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 20. Germany Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 21. France Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 28. China Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 32. India Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 34. Brazil Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Neurocutaneous Disorder Revenue Market Share, 2018-2030
Figure 37. Turkey Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Neurocutaneous Disorder Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Medtronic Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Allergan Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Syneron Medical Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Aleva NeurOthersapeutics Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Abbott Laboratories Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bausch Health Neurocutaneous Disorder Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
